Enxu Zhao
Overview
Explore the profile of Enxu Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wynn D, Goldstick L, Bauer W, Zhao E, Tarau E, Cohen J, et al.
CNS Neurosci Ther
. 2022 Jan;
28(3):364-371.
PMID: 34984839
Introduction: About 20%-35% of multiple sclerosis (MS) patients fail to respond to high-dose corticosteroids during a relapse. Repository corticotropin injection (RCI, Acthar Gel) is a naturally sourced complex mixture of...
2.
Kaplan J, Miller T, Baker M, Due B, Zhao E
Neurodegener Dis Manag
. 2021 Dec;
11(6):469-476.
PMID: 34860120
To determine whether clinicians evaluate American Academy of Neurology (AAN) quality metrics for patients with multiple sclerosis (MS) relapse and whether repository corticotropin injection (RCI) improves clinical and patient-reported outcomes...
3.
Askanase A, Wright D, Zhao E, Zhu J, Bilyk R, Furie R
Rheumatol Ther
. 2021 Sep;
8(4):1871-1886.
PMID: 34478124
Introduction: We conducted post hoc analyses of biomarker results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection (RCI; Acthar® Gel) in patients with persistently active systemic lupus...
4.
Askanase A, Zhao E, Zhu J, Bilyk R, Furie R
Rheumatol Ther
. 2021 Aug;
8(4):1915.
PMID: 34460089
No abstract available.
5.
Askanase A, Wan G, Panaccio M, Zhao E, Zhu J, Bilyk R, et al.
Rheumatol Ther
. 2021 Mar;
8(1):573-584.
PMID: 33687687
Introduction: We assessed patient-reported outcomes from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection (RCI; Acthar Gel) in patients with persistently active systemic lupus erythematosus (SLE) despite treatment...
6.
Kaplan J, Miller T, Baker M, Due B, Zhao E
Front Neurol
. 2021 Jan;
11:598496.
PMID: 33414758
Effective relapse treatment is critical for minimizing disability in patients with multiple sclerosis (MS). Repository corticotropin injection (RCI; Acthar® Gel) has demonstrated efficacy for the treatment of MS exacerbations. However,...
7.
Askanase A, Zhao E, Zhu J, Bilyk R, Furie R
Rheumatol Ther
. 2020 Sep;
7(4):893-908.
PMID: 32996096
Introduction: We assessed the efficacy and safety of repository corticotropin injection (RCI; Acthar Gel) for persistently active systemic lupus erythematosus (SLE) despite use of moderate-dose glucocorticoids. Methods: This multicenter, double-blind,...
8.
Askanase A, Zhao E, Zhu J, Connolly-Strong E, Furie R
Lupus Sci Med
. 2020 May;
7(1):e000383.
PMID: 32399253
Objective: SLE is a chronic inflammatory autoimmune disease characterised by the excessive production of autoantibodies, immune complexes and proinflammatory cytokines. Repository corticotropin injection (RCI) is a naturally sourced complex mixture...
9.
Furie R, Mitrane M, Zhao E, Becker P
Lupus Sci Med
. 2018 Jan;
4(1):e000240.
PMID: 29344387
Objective: Post hoc analyses evaluated the effectiveness and safety of repository corticotropin injection (RCI) in patients with persistently active SLE over 52 weeks. Methods: Patients were initially randomised to 40...
10.
Furie R, Mitrane M, Zhao E, Das M, Li D, Becker P
Lupus Sci Med
. 2016 Dec;
3(1):e000180.
PMID: 27933199
Objective: To evaluate the efficacy of a prolonged-release formulation of a porcine adrenocorticotropic hormone analogue (repository corticotropin injection (RCI)) added to standard of care in patients requiring moderate-dose corticosteroids for...